Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China.
Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China.
复制标题
肿瘤科医生、患者和家庭成员肺癌治疗偏好的差异：中国的半结构化定性研究
DOI：
10.2147/ppa.s299399
复制
发表时间：
2021
影响因子：
2.2
通讯作者：
Xie F
中科院分区：
文献类型：
--
作者：
He X;Zhang M;Wu J;Xu S;Jiang X;Wang Z;Zhang S;Xie F
癌症治疗决策通常需要平衡利益，危害和成本。本研究旨在确定中国肿瘤学家、患者及其家人之间癌症治疗偏好的差异。方法采用半结构式面对面定性访谈的方法，对4所三级医院的肿瘤科医生、患者及其家属进行访谈。访谈指南是在文献回顾和专家咨询的基础上制定的。参与者被要求在做出肺癌治疗决定时表明他们的偏好。所有的采访录音，逐字转录，并进行专题分析。三组参与者的偏好进行了比较。结果在2019年6月至7月期间，共采访了17名参与者（5名肿瘤学家，6对患者和家属）。确定了五个主题，即生存获益、不良反应/症状、治疗过程、治疗成本和对日常生活的影响。肿瘤科医生和家属最重视生存获益，而患者最关心的是治疗费用和生活质量。结论本研究揭示了中国肿瘤医生、患者及其家属对癌症治疗的不同偏好。在这个国家，需要教育来赋予病人和家庭成员权力，并促进共同决策。
Background Cancer treatment decision-making often needs to balance benefits, harms, and costs. This study sought to identify the differences in cancer treatment preference among oncologists, patients and their family members in China. Methods A semi-structured face-to-face qualitative interview was conducted among oncologists, patients and their family members recruited in four tertiary hospitals in China. The interview guide was developed based on literature review and expert consultation. Participants were asked to indicate their preferences when making lung cancer treatment decisions. All interviews were audio-taped, transcribed verbatim, and thematic analyzed. The preferences were compared among three groups of participants. Results A total of 17 participants (5 oncologists, 6 dyads of patients and family members) were interviewed between June and July 2019. Five themes, namely, survival benefit, adverse effect/symptom, treatment process, treatment cost, and the impact on daily life were identified. The oncologists and family members gave highest priority on survival benefit, while the patients are concerned most about treatment cost and quality of life. Conclusion This study reveals different preferences for cancer treatment among oncologists, patients and their family members in China. Education is needed to empower patients and family members and promote share decision-making in this country.